The Devyser blog

Collaboration and distribution agreement with Thermo Fisher Scientific Thermo Fisher Scientific...

Devyser´s annual report 2022 has today been published on the company´s website. The report is...

With new more sensitive diagnostics, rejection of a transplanted kidney can be detected earlier,...

Devyser, the pioneering leader in diagnostic solutions, launches today its first IVDR-certified...

“Further strong organic growth was reported for the year and quarter. Efforts to build an...

We are pleased to welcome Vertitas Corporation as a new distributor of the Devyser portfolio for...

Time is precious. Every minute, every second that we can simplify your lab’s workflow shortens the...

Conventional genetic testing for thalassemia requires the use of several techniques, leading to...

"Devyser reports yet another quarter of record sales and strong gross margins. The positive sales...

Devyser announces its decision to establish a CLIA lab in Atlanta, Georgia, USA. By operating a...

Safety: what comes to mind when you hear that word? Keeping your loved ones safe? You probably ask...

Growth. We are building for growth and consequently, we are excited to announce the launch of our...